Vizora日本語

Terumo×Nipro

Different ways of making money, on the same scale.

Same yardstick

MetricTerumoFY ending Mar 2026NiproFY ending Mar 2026
Revenue¥1.13T¥660.5B
COGS ratio47.5%68.5%
Operating margin15.6%5.7%
Net margin12.0%2.0%
FCF margin11.4%-1.2%

Highlighted = best value for that metric

Compare industry percentiles by axis

Each row uses the same 0–100 scale. Dots show each company's rank within its primary industry.

  • TerumoPrimary industry: Medical Devices
  • NiproPrimary industry: Medical Devices
CompanyRank

  • Revenue growth

    • Terumo80.338 peers
    • Nipro64.538 peers

  • Profitability

    • Terumo67.939 peers
    • Nipro21.839 peers

  • Cash conversion

    • Terumo7538 peers
    • Nipro90.838 peers

  • Efficiency

    • Terumo24.439 peers
    • Nipro29.539 peers

  • Financial strength

    • TerumoN/A
    • NiproN/A

Each dot is a company's percentile within its primary industry; peer groups may differ. Missing axes are labeled as unavailable. No combined score is calculated, and industry rank is not an investment recommendation.

Money flows side by side

Chart height is proportional to revenue.

Terumo¥1.13T · keeps ¥16 per ¥100
Nipro¥660.5B · keeps ¥6 per ¥100

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.

Open Markdown